Pakistan Bahawalpur Bahawalpur Institute of Nuclear Medicine / USA Madison University of Wisconsin / Medical Center Miriam Calaguas South Africa Johannesburg Department / Siriraj Hospital / Sao Paulo Hospital / India Institute of Medical Sciences / University of Indonesia Nana Supriana / Institute Rotary Cancer Hospital / Cipto Mangunkusumo National General Hospital / /
IndustryTerm
treatment for previously untreated locally advanced disease / cancer treatment / cancer radiotherapy treatment technologies / /
MedicalCondition
locally advanced disease / cancer / I-IV squamous cell carcinoma / tumour / future advanced cancer / viral infections / incident cancers / HNSCC cancer / squamous cell carcinomas / MS / I-II glottic carcinoma / Locally Advanced Squamous Cell Cancer / /
MedicalTreatment
Radiation therapy / radiotherapy / /
Organization
University of Indonesia / Faculty of Medicine / India New Delhi Department of Radiation Oncology / USA Madison University / Lakier Thailand Bangkok Department of Radiology / Siriraj Hospital / India Institute of Medical Sciences / Rotary Cancer Hospital / Cancer de Barretos Alexandre Jacinto Cuba La Habana Instituto Nacional de Oncología / Luke's Medical Center Miriam Calaguas South Africa Johannesburg Department of Radiation Oncology / National General Hospital / Pakistan Bahawalpur Bahawalpur Institute of Nuclear Medicine and Oncology / Sao Paulo Hospital / Misleidy Nápoles India Mumbai Advanced Centre for Treatment Research & Education / University of Wisconsin / Madison / Mahidol University / Igor Stojkovski Uruguay Montevideo Instituto / University of the Witwatersrand Roy / /
Person
Soehartati Gondhowiardjo / Jai Prakash Agarwal / Rick Chappell / Eduardo H. Zubizarreta / /
Position
RT / Scientific Secretary / /
ProvinceOrState
Wisconsin / Mississippi / /
Region
South Africa / /
Technology
Radiation / cancer radiotherapy treatment technologies / /
CRP E33035 CRP on Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (the HYPNO trial) Scientific Secretary: Eduardo H. Zubizarreta ([removed] ) Summary: